Top SellerThe proven GLP-1 for appetite and metabolic support.
Semaglutide is a long-acting GLP-1 receptor agonist that mimics the body's incretin signaling. It has reshaped modern weight management research by helping regulate appetite, slow gastric emptying, and improve glucose handling.
Activates GLP-1 receptors in the brain and gut to reduce hunger signaling, increase satiety, and improve insulin response after meals.
Typical research protocol: start 0.25 mg weekly, titrate slowly up to 1 mg weekly over several weeks.
For laboratory and research use only. Not intended for human consumption, diagnosis, treatment, cure, or prevention of any disease. All protocols are reference summaries provided for educational purposes — always consult a qualified healthcare professional.